LabMind
pathology
healthcare
genetic testing
diagnostic testing
clinical pathology laboratory
medical technology
lab management
clinical laboratory scientists
medical laboratory science
lab operations
healthcare careers
health information technology
Science
Life Sciences
Science
Life Sciences
Science
Life Sciences

LabMind

作者: ARUP Laboratories
最近更新: 4周前
<p>Join Dr. Jon Genzen, professor of pathology with the Spencer Fox Eccles School of Medicine at the...

Recent Episodes

An Interview With Dr. Brian Jackson: The LabMind Journey

An Interview With Dr. Brian Jackson: The LabMind Journey

After seven years and almost 100 episodes of LabMind recorded, Dr. Brian Jackson, former medical director at ARUP Laboratories and faculty with the Spencer Fox Eccles School of Medicine at the University of Utah, has moved into a new clinical laboratory leadership position at the University of Maryland—leaving the podcast mic behind for a clinical challenge he always knew he wanted to take in his career. During Dr. Jackson’s final episode, he shares his thoughts on a variety of topics, including the state of U.S. healthcare and the contributions of pathology, while also reflecting on his time hosting this podcast.  Related Information:• LabMind - An Interview With Dr. Carl Kjeldsberg (Part I): Founding and the Early Shaping of ARUP https://arup.utah.edu/education/podcasts/labmindEp2.php• LabMind - An Interview With Dr. Carl Kjeldsberg (Part II): Scaling ARUP into a Mature Company https://arup.utah.edu/education/podcasts/labmindEp3.php• LabMind - An Interview With Lab Superheroes: Stories of Ingenuity, Creativity, and Grit (Part II) https://arup.utah.edu/education/podcasts/labmindEp50.php• LabMind - An Interview With Rick Panning: How Laboratories Can Reduce the Total Cost of Care https://arup.utah.edu/education/podcasts/labmindEp36.php

4周前
2345
An Interview With Dr. Benjamin Bradley: The Central Role of Clinical Laboratories in Controlling Emerging Pathogens

An Interview With Dr. Benjamin Bradley: The Central Role of Clinical Laboratories in Controlling Emerging Pathogens

Whenever a new infectious disease enters the scene (or reenters, as in the case of measles), developing precise and accurate diagnostic tests as quickly as possible is critical. In this interview, Dr. Ben Bradley, ARUP medical director of the Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, describes various challenges in rapidly setting up and maintaining testing capacity for these kinds of diseases and why we need collaboration between academic, clinical, and public health labs.Webinar: Emerging Viral Diseases: A 2025 Update for Laboratorians [https://arup.utah.edu/education/bradley-emergingviral-2025.php]; Measles by Real-Time PCR: A Rapid and Reliable Method for Measles Testing [https://www.youtube.com/watch?v=NZdZDPv-oTw]

5个月前
2453
An Interview With Dr. Ryan Metcalf: The Art and Science of Creating a Clinical Guideline

An Interview With Dr. Ryan Metcalf: The Art and Science of Creating a Clinical Guideline

In this age of algorithms, how do we ensure clinical care is both science based and personalized? In this interview, Dr. Ryan Metcalf, section chief of Transfusion Medicine at ARUP Laboratories and University of Utah Health and associate professor of Pathology at the University of Utah School of Medicine, shares the story behind the new platelet transfusion guideline from the Association for the Advancement of Blood and Biotherapies (AABB). He describes how the authors addressed patient-specific variation and the inherent uncertainty of scientific evidence. Related Information: Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines [https://arup.utah.edu/education/metcalf-platelet-2025.php/]JAMA® Article: Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines [https://jamanetwork.com/journals/jama/fullarticle/2834703]JAMA® Clinical Reviews Podcast: Platelet Transfusion: Best Practice Guidelines [https://edhub.ama-assn.org/jn-learning/audio-player/18977738]

6个月前
2689
An Interview With Beverly Rauch: Regulating the Safety and Effectiveness of Clinical Laboratory Testing

An Interview With Beverly Rauch: Regulating the Safety and Effectiveness of Clinical Laboratory Testing

Many people in the healthcare profession know that clinical laboratories are under more rigorous regulatory scrutiny than just about any other area of medicine. What they may not know is that the New York State Department of Health (NY DOH) was the pioneer in laboratory regulation, starting long before the implementation of either the FDA Medical Device Amendments or the Clinical Laboratory Improvement Amendments (CLIA) of 1988. In this interview, Beverly Rauch, MS, director of the NY DOH’s Clinical Laboratory Evaluation Program (NY CLEP), describes its process for granting permits, inspecting laboratories, and approving assays, and what the new FDA LDT rule might mean for the program.

13个月前
1993
An Interview With Dr. Jonathan Genzen: Answering Your Questions About the FDA’s Final Rule on LDTs

An Interview With Dr. Jonathan Genzen: Answering Your Questions About the FDA’s Final Rule on LDTs

As of September 2024, there remains enormous uncertainty about the FDA’s final rule on laboratory-developed tests (LDTs). Will it hold up in court? Which tests are subject to which requirements? How can laboratories best prepare? In this interview, Dr. Jonathan Genzen, ARUP’s chief medical officer and senior director of governmental affairs, responds to questions sent in by members of the laboratory community. Related Information: ARUP Resources on the FDA’s Final Rule on Laboratory-Developed Tests (https://www.aruplab.com/fda-ldt-final-rule)ARUP Webinar--The FDA’s Final Rule on LDTs: What You Need To Know (https://youtu.be/nGQ3sRfWkBg)ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests (https://www.aruplab.com/news/05-30-2024/arup-files-declaration-support-lawsuit-challenging-fdas-rule) FDA email address for questions on the final rule: (ldtfinalrule@fda.hhs.gov)

2024/9/10
2634
An Interview With Dr. Vikas Saini: Creating a More Just, Effective, and Affordable Healthcare System

An Interview With Dr. Vikas Saini: Creating a More Just, Effective, and Affordable Healthcare System

Fixing American healthcare will require more than mere tweaks around the edges. Dr. Vikas Saini, president of the Boston-based Lown Institute, believes that it will require a return to medicine’s humanist roots. In this interview he describes some of the ways in which many healthcare organizations prioritize revenue and profit over patients and communities. He also explains why he remains optimistic that Hippocratic principles will ultimately prevail. Related Information: Lown Institute (https://lowninstitute.org/)2024 Top Hospitals: America’s Most Socially Responsible Hospitals (https://lownhospitalsindex.org/the-most-socially-responsible-hospitals-in-the-u-s-2024/)2023 Shkreli Awards: The Lown Institute’s Top Ten List of the Worst Examples of Profiteering and Dysfunction in Healthcare (https://lowninstitute.org/projects/2023-shkreli-awards/)

2024/8/13
2396
An Interview With Dr. Ryan Metcalf: Why Quality Management Is Critical to the Long-Term Success of Healthcare AI

An Interview With Dr. Ryan Metcalf: Why Quality Management Is Critical to the Long-Term Success of Healthcare AI

A public debate is raging around the regulation of artificial intelligence (AI). One side argues that AI is potentially dangerous and needs to be carefully controlled, whereas the other side argues that any regulation would slow innovation. In this interview, Dr. Ryan Metcalf, section chief of Transfusion Medicine and medical director of Transfusion Service/Blood Bank at ARUP Laboratories, makes a strong case for a safety-first approach to healthcare AI. He also explains why embedding AI development and use within a strong quality management framework could actually lead to more innovation over the long term, even as it prevents patient harm in the short term.RELATED INFORMATION:  Creation and Adoption of Large Language Models in Medicine 

2023/11/30
2181
An Interview With Drs. Meghan Delaney and Eric Konnick: How FDA Restrictions on Laboratory-Developed Tests Will Harm Patients and Increase Costs

An Interview With Drs. Meghan Delaney and Eric Konnick: How FDA Restrictions on Laboratory-Developed Tests Will Harm Patients and Increase Costs

The FDA recently announced a plan to regulate laboratory-developed tests (LDTs) as medical devices. In this interview, Dr. Meghan Delaney from Children’s National Hospital and Dr. Eric Konnick from the University of Washington explain why many tests that are critical to patient care, particularly in the areas of pediatrics, transplantation, and rare diseases, may become unavailable if the rule the FDA has proposed is enacted. Other tests may remain available, but at a significantly increased cost. Dr. Jonathan Genzen, ARUP’s chief medical officer and cohost of this episode, describes how laboratory professionals can provide public feedback to the FDA before the rule takes effect.Related Information:Click Here to access the FDA public comment webpage for the newly proposed LDT rule. ARUP Joins Industry Partners in Opposing Proposed FDA Rules Seeking to Regulate Laboratory-Developed Tests ACLA Opposes Unilateral FDA Action to Regulate Laboratory Developed Tests Under Medical Device Authority Laboratory-Developed Tests Account for a Small Minority of Tests Ordered in an Academic Hospital System Laboratory-Developed Tests: A Legislative and Regulatory Review 

2023/11/6
2505
An Interview With Dr. Ila Singh: What the TRUU-Lab Initiative Has Taught Us About Laboratory Test Names

An Interview With Dr. Ila Singh: What the TRUU-Lab Initiative Has Taught Us About Laboratory Test Names

Dr. Ila Singh, chief of laboratory medicine at Texas Children’s Hospital, founded the Test Renaming for Understanding and Utilization in the Laboratory (TRUU-Lab) initiative several years ago to tackle challenges related to the nonstandardized and uninformative naming of laboratory tests. In this interview, Dr. Singh describes the surveys her CDC-funded collaborative has conducted with hundreds of physicians and other providers, and she shares insights about how to improve the ordering of tests through more effective naming.Related Information:Click Here to Listen to this Podcast Episode on the ARUP EDU Official Website.Click Here to Listen to Dr. Singh's 2019 Appearance on LabMind Entitled "An Interview with Dr. Ila Singh: The TRUU-Lab Initiative to Improve Laboratory Test Names." Click Here to View Dr. Singh's 2019 Video Lecture Entitled "Ordering the Right Lab Test: It All Begins With the Right Test Name."

2023/10/19
1486
An Interview With Glen Garrick: Sustainability in Healthcare Organizations

An Interview With Glen Garrick: Sustainability in Healthcare Organizations

Sustainability is a hot topic for American corporations, and health systems are no exception. In this interview, Glen Garrick, system sustainability director for Intermountain Healthcare, explains how his and other healthcare organizations are addressing their environmental, social, and governance responsibilities. He also describes how clinical laboratories can make the most positive impact.Related Information:New Building Embodies ARUP’s Commitment to Environmental StewardshipARUP’s Environmental Sustainability Efforts Pay OffRecycling Coalition of Utah Names ARUP the Thomas A. Martin Business Recycler of the Year Impressive New Structure Will Enhance ARUP’s Environmental Stewardship Efforts  Top 10 Ways ARUP Helps Our Environment Click Here to Listen to This Episode from the ARUP Website 

2023/8/17
2256
An Interview With Dr. Marc Couturier: Keys to Laboratory Success in the Next Pandemic

An Interview With Dr. Marc Couturier: Keys to Laboratory Success in the Next Pandemic

Three and a half years after the emergence of COVID-19 is a good time to reflect on the capabilities of U.S. laboratories to respond to future pandemics. In this interview, Dr. Marc Couturier, medical director of Emerging Public Health Crises at ARUP Laboratories, explains how the U.S. laboratory sector has improved in its ability to respond quickly to emerging and reemerging infections, but he emphasizes the need to go further. He specifically explains why testing can’t be rapidly scaled up unless there’s tight coordination between public health labs and clinical labs (particularly reference labs and large academic labs).Click here to Register for Dr. Marc Couturier's Upcoming Webinar entitled: “How to Avoid Building an Airplane Mid Flight: Lab Medicine in the Face of Emerging Public Health Crises” Click Here to Listen to this Episode on ARUP's Official Website. 

2023/8/1
2401